Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19
Dermatol Ther
.
2021 Mar;34(2):e14806.
doi: 10.1111/dth.14806.
Epub 2021 Feb 24.
Authors
Işın Nur Sultan Öncü
1
,
Dilara Güler
1
,
Gülhan Gürel
1
Affiliation
1
Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
PMID:
33486832
PMCID:
PMC7995161
DOI:
10.1111/dth.14806
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Drug Treatment*
Humans
Hydroxychloroquine / adverse effects
Psoriasis* / chemically induced
Psoriasis* / diagnosis
Psoriasis* / drug therapy
SARS-CoV-2
Substances
Hydroxychloroquine